Literature DB >> 33026110

Inflammation of papillae of Wharton's duct in COVID-19 patients: A debatable entity.

Abdul Salam Afsal1, Najma Musthafa2, Mundekattil Sulaiman Fathima1, Geetha Gopalakrishnan Lakshmi1.   

Abstract

Entities:  

Keywords:  COVID-19; Wharton's duct; submandibular salivary gland

Mesh:

Year:  2020        PMID: 33026110      PMCID: PMC7675480          DOI: 10.1111/scd.12526

Source DB:  PubMed          Journal:  Spec Care Dentist        ISSN: 0275-1879


× No keyword cloud information.
Dear Editor, Novel coronavirus outbreak is one of the greatest challenges that we are facing as it is highly pathogenic and transmissible. Owing to safety concerns, many patients with suspected or confirmed coronavirus disease (COVID‐19) do not have their oral cavity examined for oral manifestations. Although the presence of 2019‐nCoV in oral cavity and saliva is a proven fact, only a few articles are published with regard to salivary gland manifestation in COVID‐19 patients. It is known that ACE2 receptors play an important role in cellular entry of 2019‐nCoV. Thus, ACE2 expressing cells may act as target cells and indicate potential infectious route. A high expression of ACE2 in oral cavity especially tongue, floor of mouth, and salivary gland might provide possible routes of entry for the 2019‐nCoV. Liu et al analyzed rhesus macaques and found expression of ACE2 in epithelial cell lining on minor salivary gland ducts. Chen et al revealed the expression of ACE2 receptor in human granular cells in salivary glands, which can actually be a target site for 2019‐nCoV. Fisher et al reported parotitis in a diagnosed case of COVID‐19. Here, we describe the inflammation of papillae of Wharton's duct seen in three patients diagnosed with COVID‐19. About six patients with mild symptoms like fever, myalgia, and throat pain were tested positive for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by RT‐PCR at Kadakkal Government Taluk Hospital, Kerala by June 11, 2020. A thorough oral examination with the aid of intra oral photography revealed that three cases showed moderate inflammation of papillae of Wharton's duct (Figure 1).The submandibular salivary glands were nontender on palpation, and there was no other associated salivary gland pathology, which may present as inflammation of Wharton's duct except for hypo salivation. These three patients slowly improved and recovered completely within 2 weeks period. By the time mentioned, the inflammation of papillae of Wharton's duct seemed to be more pronounced (Figure 2).
FIGURE 1

Moderate inflammation of papillae of Wharton's duct

FIGURE 2

Pronounced inflammation of papillae of Wharton's duct

Moderate inflammation of papillae of Wharton's duct Pronounced inflammation of papillae of Wharton's duct Recent studies have proved the presence of SARS‐CoV‐2 RNA copies in the saliva of asymptomatic and symptomatic cases. Wang et al suggested the possibilities of acute and chronic sialadenitis in patients infected with SARS‐CoV‐2. Being able to promptly recognize and diagnose oral lesions is critical as it may help us to better understand the disease process. Further studies need to be carried out in larger cohorts of patients.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

AUTHOR CONTRIBUTIONS

A. S. Afsal, Najma Musthafa, M. S. Fathima, and G. G. Lakshmi collected and analyzed clinical data, wrote the manuscript, and revised the article.

ETHICS STATEMENT

All procedures followed were in accordance with the 1964 Helsinki declaration and its later amendments.
  6 in total

1.  Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.

Authors:  Li Liu; Qiang Wei; Xavier Alvarez; Haibo Wang; Yanhua Du; Hua Zhu; Hong Jiang; Jingying Zhou; Pokman Lam; Linqi Zhang; Andrew Lackner; Chuan Qin; Zhiwei Chen
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  COVID-19 associated parotitis.

Authors:  Jennifer Fisher; Derek L Monette; Krupa R Patel; Brendan P Kelley; Maura Kennedy
Journal:  Am J Emerg Med       Date:  2020-06-27       Impact factor: 2.469

3.  Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?

Authors:  Chenxing Wang; Heming Wu; Xu Ding; Huan Ji; Pengfei Jiao; Haiyang Song; Sheng Li; Hongming Du
Journal:  Med Hypotheses       Date:  2020-04-24       Impact factor: 1.538

4.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.

Authors:  Xin Zou; Ke Chen; Jiawei Zou; Peiyi Han; Jie Hao; Zeguang Han
Journal:  Front Med       Date:  2020-03-12       Impact factor: 4.592

5.  High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.

Authors:  Hao Xu; Liang Zhong; Jiaxin Deng; Jiakuan Peng; Hongxia Dan; Xin Zeng; Taiwen Li; Qianming Chen
Journal:  Int J Oral Sci       Date:  2020-02-24       Impact factor: 6.344

6.  Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.

Authors:  Anne L Wyllie; John Fournier; Arnau Casanovas-Massana; Melissa Campbell; Maria Tokuyama; Pavithra Vijayakumar; Joshua L Warren; Bertie Geng; M Catherine Muenker; Adam J Moore; Chantal B F Vogels; Mary E Petrone; Isabel M Ott; Peiwen Lu; Arvind Venkataraman; Alice Lu-Culligan; Jonathan Klein; Rebecca Earnest; Michael Simonov; Rupak Datta; Ryan Handoko; Nida Naushad; Lorenzo R Sewanan; Jordan Valdez; Elizabeth B White; Sarah Lapidus; Chaney C Kalinich; Xiaodong Jiang; Daniel J Kim; Eriko Kudo; Melissa Linehan; Tianyang Mao; Miyu Moriyama; Ji E Oh; Annsea Park; Julio Silva; Eric Song; Takehiro Takahashi; Manabu Taura; Orr-El Weizman; Patrick Wong; Yexin Yang; Santos Bermejo; Camila D Odio; Saad B Omer; Charles S Dela Cruz; Shelli Farhadian; Richard A Martinello; Akiko Iwasaki; Nathan D Grubaugh; Albert I Ko
Journal:  N Engl J Med       Date:  2020-08-28       Impact factor: 176.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.